PathoFinder wants to set a new standard for diagnosing infectious diseases in humans. To this end, PathoFinder has developed proprietary technology where a single test can determine the presence of up to twenty-five different pathogens. This technology is based on the genetic material (DNA or RNA) of the microorganisms involved. The most significant PathoFinder product is the RespiFinder SMART 22, which is capable of detecting the most common and most relevant pathogens of respiratory tract infection and is already in use as a standard test in leading laboratories in Europe.

Version: 22/12/2017